|
MonocidDrug - Monocid The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Cefonicid Sodium
Strength -
EQ 10GM BASE/VIAL
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
050579
Product Number -
004
Therapeutic Equivalence (TE) Code -
Approval Date -
May 23, 1984
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Monocid
Suprax 400mg Tablet; Oral
Suprax 400mg Tablet; Oral Cefmax Eq 1gm Base/vial Injectable; Injection Cefmax Eq 2gm Base/vial Injectable; Injection Cefmax Eq 500mg Base/vial Injectable; Injection Zefazone Eq 1gm Base/vial Injectable; Injection Zefazone Eq 2gm Base/vial Injectable; Injection Zefazone In Plastic Container Eq 20mg Base/ml Injectable; Injection Zefazone In Plastic Container Eq 40mg Base/ml Injectable; Injection Monocid Eq 10gm Base/vial Injectable; Injection NewDrugInformation |